Thomas Niel

Thomas Niel

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

The 7 Best Cheap Stocks Under $10 to Buy Now

Still at deep value prices, consider now a great time to enter a position in each of these seven best cheap stocks under $10 per share.

The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond

As their respective catalysts (namely new treatments/products) continue to play out, each one of these seven hottest healthcare stocks has a strong chance of making another significant move higher in 2023, and in the years ahead.

The 7 Hottest Penny Stocks to Own for 2023 and Beyond

Company-specific catalysts could help these seven hottest penny stocks deliver outsized returns in 2023, and in the years ahead.

7 EV Stocks to Sell Before They Dead End

Although the EV bubble popped well over a year ago, substantial downside risk remains with these seven EV stocks to sell.

7 Big-Name Stocks Hedge Funds are Selling

When it comes to stocks hedge funds are selling, the 'smart money' has bailed on these seven well-known names.

Even After This Year’s Melt-Up, Runway Remains for LLY Stock

Far from topping out, LLY stock remains a solid opportunity among healthcare stocks.

7 Real Estate Stocks to Sell…and 1 to Buy

As the downturn continues, sell these 7 real estate stocks, but add this one deep value real estate play to your portfolio.

7 Stocks Rattled by Corporate Scandals and Shenanigans in 2022

However, whether guilty of the "crime," or merely struggling to put allegations behind them, the question is whether these seven corporate scandal stocks can make a recovery. Let's dive into each one, and see if a comeback is possible.

7 Penny Stocks Smart Investors Shouldn’t Touch With a 10-Foot Pole

Don't let the recent bull market rally fool you into thinking these seven penny stocks to avoid are worthwhile moonshots.

7 Tech Stocks Smart Investors Shouldn’t Touch with a 10-Foot Pole

These seven tech stocks to avoid are experiencing massive declines this year, but each one is still likely to move lower.